Listed

Pfizer Inc

PFENYSECIK 78003HealthcareFiscal year ends Dec 31

Reports and events: 369 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Pfizer Inc, Reports and events
FiledFormWhat it isAccession number
2022-03-2916:31 ET8-K8.01 Other events0001193125-22-088144
2022-03-2116:25 ETSC 13DOwnership report, active investor0000078003-22-000045
2022-03-1709:53 ETDEF 14AProxy statementPeriod 2022-04-280000078003-22-000038
2022-02-2414:25 ET10-KAnnual reportPeriod 2021-12-310000078003-22-000027
2022-02-0808:53 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000078003-22-000003
2021-12-1516:18 ET8-K5.02 Departure or appointment of officers or directors0000078003-21-000118
2021-11-1916:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000078003-21-000114
2021-11-1206:06 ET10-QQuarterly reportPeriod 2021-10-030000078003-21-000107
2021-11-0208:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000078003-21-000104
2021-09-1716:27 ETSC 13D/AOwnership report, active investor, amended0000078003-21-000099
2021-09-1716:17 ETSC 13D/AOwnership report, active investor, amended0000078003-21-000098
2021-08-1816:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-250347
2021-08-1216:01 ET10-QQuarterly reportPeriod 2021-07-040000078003-21-000093
2021-07-2808:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000078003-21-000090
2021-07-0916:38 ET8-K5.02 Departure or appointment of officers or directors0000078003-21-000087
2021-07-0916:16 ETSC 13D/AOwnership report, active investor, amended0000078003-21-000083
2021-05-1311:32 ET10-QQuarterly reportPeriod 2021-04-040000078003-21-000065
2021-05-0408:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000078003-21-000062
2021-04-2609:30 ET8-K5.07 Shareholder vote results0000078003-21-000059
2021-03-1209:32 ETDEF 14AProxy statementPeriod 2021-04-220000078003-21-000047
2021-02-2513:59 ET10-KAnnual reportPeriod 2020-12-310000078003-21-000038
2021-02-0213:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000078003-21-000003
2021-01-1215:59 ET8-K7.01 Regulation FD disclosure0001193125-21-006923
2020-12-1422:01 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-20-317074
2020-11-2023:38 ET8-K2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-20-298356
2020-11-1821:32 ET8-K8.01 Other events0001193125-20-296989
2020-11-1621:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-294847
2020-11-1322:05 ET8-K3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-20-293176
2020-11-0621:10 ETSC 13DOwnership report, active investor0000078003-20-000074
2020-11-0521:57 ET10-QQuarterly reportPeriod 2020-09-270000078003-20-000070
2020-11-0521:42 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-286896
2020-10-3021:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-282739
2020-10-2712:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000078003-20-000065
2020-08-0621:23 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-212094
2020-08-0620:10 ET10-QQuarterly reportPeriod 2020-06-280000078003-20-000060
2020-07-2812:28 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000078003-20-000056
2020-06-2621:03 ET8-K8.01 Other events0001193125-20-181098
2020-06-0121:25 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-20-157434
2020-05-2820:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-154311
2020-05-2220:44 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-150192
2020-05-1920:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-146185
2020-05-0714:42 ET10-QQuarterly reportPeriod 2020-03-290000078003-20-000037
2020-04-2812:26 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000078003-20-000034
2020-04-2416:38 ET8-K5.07 Shareholder vote results0000078003-20-000031
2020-04-0213:53 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000078003-20-000029
2020-03-2721:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000930413-20-000918
2020-03-1320:30 ETDEF 14AProxy statementPeriod 2020-04-230000930413-20-000781
2020-03-0417:26 ET8-K5.02 Departure or appointment of officers or directors0000078003-20-000021
2020-03-0220:03 ET8-K5.02 Departure or appointment of officers or directors0000078003-20-000019
2020-02-2801:51 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000078003-20-000016

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 18:08 ET. Listed shows no prices and gives no investment advice.